dc.contributor.author | Guven, A | |
dc.contributor.author | Karadeniz, S | |
dc.contributor.author | Aydin, O | |
dc.contributor.author | Akbalik, M | |
dc.contributor.author | Aydin, M | |
dc.date.accessioned | 2020-06-21T15:37:34Z | |
dc.date.available | 2020-06-21T15:37:34Z | |
dc.date.issued | 2005 | |
dc.identifier.issn | 0301-0163 | |
dc.identifier.uri | https://doi.org/10.1159/000087288 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12712/21254 | |
dc.description | AYDIN, MURAT/0000-0001-7374-229X; GUVEN, AYLA/0000-0002-2026-1326 | en_US |
dc.description | WOS: 000231630800007 | en_US |
dc.description | PubMed: 16088205 | en_US |
dc.description.abstract | Corticosteroids, even in topical application, may cause immunosuppression and Cushing's syndrome. A case of disseminated fatal cytomegalovirus infection is reported in a 3-month-old girl with Cushing's syndrome caused by exogenous topical clobetasol propionate application, which might have caused immunosuppression due to prolonged use. Copyright (C) 2005 S. Karger AG, Basel. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Karger | en_US |
dc.relation.isversionof | 10.1159/000087288 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Cushing's syndrome | en_US |
dc.subject | cytomegalovirus infection | en_US |
dc.subject | clobetasol propionate | en_US |
dc.subject | fatty liver | en_US |
dc.title | Fatal disseminated cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid | en_US |
dc.type | article | en_US |
dc.contributor.department | OMÜ | en_US |
dc.identifier.volume | 64 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 35 | en_US |
dc.identifier.endpage | 38 | en_US |
dc.relation.journal | Hormone Research | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |